IMPACT OF LESION COMPLEXITY ON PCI SUCCESS IN LAD DISEASE: A RETROSPECTIVE STUDY

Authors

  • T DURRANI Department of Cardiology, Northwest General Hospital and Research Center, Peshawar, Pakistan
  • A SYEDA Department of Cardiology Hayatabad Medical Complex, Peshawar, Pakistan, Pakistan
  • I HUSSAIN Department of Cardiology Hayatabad Medical Complex, Peshawar, Pakistan, Pakistan
  • P KHAN Department of Cardiology, Northwest General Hospital and Research Center, Peshawar, Pakistan
  • K QAYYUM Department of Cardiology, Northwest General Hospital and Research Center, Peshawar, Pakistan
  • H DURRANI Department of Cardiology Hayatabad Medical Complex, Peshawar, Pakistan, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1153

Keywords:

coronary artery disease, LAD, PCI, lesion complexity, restenosis, SYNTAX score, MACE

Abstract

Coronary artery disease (CAD) involving the left anterior descending (LAD) artery is a major cause of morbidity and mortality globally. The prognosis of patients with coronary artery disease depends on the extent of at-risk myocardium. LAD comparatively supplies a large percentage of the left ventricle compared to RCA or LCX. The principal indication of percutaneous coronary intervention is to improve the quality of life in patients with angina refractory to medications. There are many advancements in PCI techniques for better management of challenging lesions due to physiological, anatomical, or functional difficulties. Some of the complex lesions include ostial lesions, bifurcating lesions, calcified lesions, and chronic total occlusions. However, as lesion complexity plays a significant role in procedural success and long-term outcomes, complex lesions are often associated with increased rates of restenosis, adverse events, and procedural challenges Objective: This study aims to evaluate the impact of lesion complexity on PCI success in patients with LAD disease. Methods: This retrospective cohort study was conducted from January 1, 2021, to December 31, 2023, at a tertiary cardiovascular center. A total of 216 participants who had PCI to LAD lesions done were included. Lesion complexity was assessed using the SYNTAX score and categorised into low, intermediate, and high complexity groups. The primary outcome was restenosis at 12 months, defined as ≥50% luminal narrowing in patients requiring repeat angiography due to any indication. Secondary outcomes included procedural success, major adverse cardiac events (MACE), and rates of stent thrombosis. Data were analysed using SPSS version 24.0, with statistical significance set at p < 0.05. Results: Among the 216 participants, 72% were male, and the mean age was 61.4 ± 9.8 years. Restenosis occurred in 13.9% of participants, with higher rates observed in patients with high-complexity lesions (24.5%) compared to low-complexity lesions (7.7%) (p = 0.02). Procedural success was achieved in 92.6% of cases, though it decreased with increasing lesion complexity (97.8% for low, 93.4% for intermediate, and 85.7% for high-complexity groups). MACE occurred in 4.6% of participants, with stent thrombosis noted in 2.7%. Conclusion: Lesion complexity significantly influences PCI success and restenosis rates in LAD disease. Patients with higher complexity lesions experience worse outcomes, necessitating individualised treatment strategies to optimise procedural success.

Downloads

Download data is not yet available.

References

O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4). doi:10.1016/j.jacc.2012.11.019

Genereux P, Palmerini T, Caixeta A, et al. Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention: The SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) Trial at 5 Years. JACC Cardiovasc Interv. 2013;6(5):505-514. doi:10.1016/j.jcin.2013.02.006

Farooq V, van Klaveren D, Steyerberg EW, et al. Anatomical and clinical characteristics to guide decision-making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013;381(9867):639-50. doi:10.1016/S0140-6736(13)60108-7

Nakazato R, Park HB, Berman DS, et al. Non-invasive fractional flow reserve derived from coronary CT angiography for intermediate stenoses: results from the DeFACTO study. J Am Coll Cardiol. 2013;63(12):1145-55. doi:10.1016/j.jacc.2013.09.009

Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629-38. doi:10.1016/S0140-6736(13)60141-5

Stone GW, Sabik JF, Serruys PW, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med. 2016;375(23):2223-35. doi:10.1056/NEJMoa1610227

Costa JR, Mintz GS, Carlier SG, et al. Impact of lesion complexity on long-term outcomes after percutaneous coronary intervention. J Am Coll Cardiol. 2007;50(12):1195-1200. doi:10.1016/j.jacc.2007.04.099

Kastrati A, Mehilli J, Pache J, et al. Analysis of 1,450 patients treated with drug-eluting stents or bare-metal stents for complex coronary lesions. Circulation. 2006;113(10):1624-1631. doi:10.1161/CIRCULATIONAHA.105.592105

Nakazawa G, Finn AV, Vorpahl M, et al. Relation of clinical presentation, lesion morphology, and drug-eluting stent type to late stent thrombosis. J Am Coll Cardiol. 2009;54(21):2293-2301. doi:10.1016/j.jacc.2009.07.036

Genereux P, Palmerini T, Caixeta A, et al. Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention: The SYNTAX Trial at 5 Years. JACC Cardiovasc Interv. 2013;6(5):505-514. doi:10.1016/j.jcin.2013.02.006

SYNTAX II trial investigators. SYNTAX II: Five-year outcomes from a multicentre randomized trial. Lancet. 2021;397(10282):1015-1024. doi:10.1016/S0140-6736(21)00187-5

Maehara A, Matsumura M, Ali ZA, et al. IVUS-Guided Versus OCT-Guided Stent Implantation: A Meta-Analysis. J Am Coll Cardiol. 2021;77(9):1153-1166. doi:10.1016/j.jacc.2021.01.016

Mauri L, Kereiakes DJ, Yeh RW, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014;371(23):2155-2166. doi:10.1056/NEJMoa1409312

Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. Circulation. 2014;130(19):1749-1767. doi:10.1161/CIR.0000000000000095

Kimura T, Abe K, Morimoto T, et al. Long-Term Outcomes of Percutaneous Coronary Intervention With Drug-Eluting Stents for Left Main Coronary Artery Disease: Extended Follow-Up of the NOBLE and EXCEL Trials. Lancet. 2021;397(10282):1341-1349. doi:10.1016/S0140-6736(21)00326-1

Valgimigli M, Bueno H, Byrne RA, et al. 2018 ESC/EACTS Guidelines on Myocardial Revascularization. Eur Heart J. 2018;39(2):79-119. doi:10.1093/eurheartj/ehy394

Downloads

Published

2024-09-30

How to Cite

DURRANI , T., SYEDA , A., HUSSAIN , I., KHAN , P., QAYYUM , K., & DURRANI , H. (2024). IMPACT OF LESION COMPLEXITY ON PCI SUCCESS IN LAD DISEASE: A RETROSPECTIVE STUDY. Biological and Clinical Sciences Research Journal, 2024(1), 1153. https://doi.org/10.54112/bcsrj.v2024i1.1153